Funder: NIH: National Institute of Allergy and Infectious Diseases (NIAID)

Topics: Biomarkers, Clinical Presentation of Infection, Pneumonia, Clinical Trial, Co-Morbidities, Community Engagement, Computational Analysis, Diagnostics, Diagnostic Efficacy, Diagnostic Reliability, Diagnostic Scalability, Viral Detection, Economic Impact, ELSI (Ethical, Legal, and Social Implications), Epidemiology, Clinical History, Clinical Outcome, Incidence, Risk Factors, Aerosol, Health Disparities, Healthcare Implementation, Immunity, Immunology, Host Factors, Host Response, Mobile Health, Organ, Prevention, Prognostics, Cell Culture, Research Model Development, Mouse Models, Organoid Models, Research Tool Development, Target Population, Treatments, Antibody-based Treatment, Convalescent Serum, Drug Development, Drug Repurposing, Drug Treatment, Drugs, Immunological Response Targets, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Virology, Viral Interactome, Viral Proteins, Virus Biology